Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer

Clinical trial NCT06107868 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06107868
Sponsor: University Health Network, Toronto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer Recurrent Uterine Cancer Metastatic Cancer Advanced Cancer

Start date: 2024-03-20
Primary completion: 2025-10-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.